421 related articles for article (PubMed ID: 26486929)
1. Sodium channel blockers for neuroprotection in multiple sclerosis.
Yang C; Hao Z; Zhang L; Zeng L; Wen J
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010422. PubMed ID: 26486929
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Teriflunomide for multiple sclerosis.
He D; Zhang C; Zhao X; Zhang Y; Dai Q; Li Y; Chu L
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009882. PubMed ID: 27003123
[TBL] [Abstract][Full Text] [Related]
4. Siponimod for multiple sclerosis.
Cao L; Li M; Yao L; Yan P; Wang X; Yang Z; Lao Y; Li H; Yang K; Li K
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013647. PubMed ID: 34783010
[TBL] [Abstract][Full Text] [Related]
5. Dietary interventions for multiple sclerosis-related outcomes.
Parks NE; Jackson-Tarlton CS; Vacchi L; Merdad R; Johnston BC
Cochrane Database Syst Rev; 2020 May; 5(5):CD004192. PubMed ID: 32428983
[TBL] [Abstract][Full Text] [Related]
6. Teriflunomide for multiple sclerosis.
He D; Xu Z; Dong S; Zhang H; Zhou H; Wang L; Zhang S
Cochrane Database Syst Rev; 2012 Dec; 12():CD009882. PubMed ID: 23235682
[TBL] [Abstract][Full Text] [Related]
7. Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.
Filippini G; Del Giovane C; Clerico M; Beiki O; Mattoscio M; Piazza F; Fredrikson S; Tramacere I; Scalfari A; Salanti G
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD012200. PubMed ID: 28440858
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in people with multiple sclerosis.
Jagannath VA; Pucci E; Asokan GV; Robak EW
Cochrane Database Syst Rev; 2019 May; 5(5):CD009903. PubMed ID: 31150100
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D for the management of multiple sclerosis.
Jagannath VA; Filippini G; Di Pietrantonj C; Asokan GV; Robak EW; Whamond L; Robinson SA
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD008422. PubMed ID: 30246874
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.
Filippini G; Del Giovane C; Vacchi L; D'Amico R; Di Pietrantonj C; Beecher D; Salanti G
Cochrane Database Syst Rev; 2013 Jun; (6):CD008933. PubMed ID: 23744561
[TBL] [Abstract][Full Text] [Related]
11. Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial.
Kapoor R; Furby J; Hayton T; Smith KJ; Altmann DR; Brenner R; Chataway J; Hughes RA; Miller DH
Lancet Neurol; 2010 Jul; 9(7):681-8. PubMed ID: 20621711
[TBL] [Abstract][Full Text] [Related]
12. Alemtuzumab for multiple sclerosis.
Riera R; Porfírio GJ; Torloni MR
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011203. PubMed ID: 27082500
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological treatment for memory disorder in multiple sclerosis.
He D; Zhang Y; Dong S; Wang D; Gao X; Zhou H
Cochrane Database Syst Rev; 2013 Dec; (12):CD008876. PubMed ID: 24343792
[TBL] [Abstract][Full Text] [Related]
14. Rituximab for people with multiple sclerosis.
Filippini G; Kruja J; Del Giovane C
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013874. PubMed ID: 34748215
[TBL] [Abstract][Full Text] [Related]
15. Corneal collagen cross-linking for treating keratoconus.
Sykakis E; Karim R; Evans JR; Bunce C; Amissah-Arthur KN; Patwary S; McDonnell PJ; Hamada S
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010621. PubMed ID: 25803325
[TBL] [Abstract][Full Text] [Related]
16. Mitoxantrone for multiple sclerosis.
Martinelli Boneschi F; Vacchi L; Rovaris M; Capra R; Comi G
Cochrane Database Syst Rev; 2013 May; (5):CD002127. PubMed ID: 23728638
[TBL] [Abstract][Full Text] [Related]
17. Laquinimod for multiple sclerosis.
He D; Han K; Gao X; Dong S; Chu L; Feng Z; Wu S
Cochrane Database Syst Rev; 2013 Aug; (8):CD010475. PubMed ID: 23922214
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.
Tramacere I; Del Giovane C; Salanti G; D'Amico R; Filippini G
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD011381. PubMed ID: 26384035
[TBL] [Abstract][Full Text] [Related]
19. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
[TBL] [Abstract][Full Text] [Related]
20. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
